| Human miRNAs |
Sequence Alignment |
Identity |
% Identity |
| hsa-miR-599 |
Variola 153794 GTTGTGTCAGTTTATAATAAC 153814
|||||||||||||||.| |||
hsa-miR-599 1 GTTGTGTCAGTTTATCA-AAC 20
Vaccinia 164972 GTTGTGTCAGTTTATAATAAC 164992
|||||||||||||||.| |||
hsa-miR-599 1 GTTGTGTCAGTTTATCA-AAC 20 |
19/21
19/21 |
(90.5%)
(90.5%) |
| hsa-miR-876-3p |
Variola 36470 TGGTTCAGAAAGTAATTCA 36488
|||||.|.|||||||||||
hsa-miR-876 4 TGGTTTACAAAGTAATTCA 22
Vaccinia 45611 TGGTTCAGAAAGTAATTCA 45629
|||||.|.|||||||||||
hsa-miR-876 4 TGGTTTACAAAGTAATTCA 22 |
17/19
17/19 |
(89.5%)
(89.5%) |
| hsa-miR-488-3p |
Variola 70224 TTGAAA-ACTATTTCTTGG 70241
|||||| .|||||||||||
hsa-miR-488 1 TTGAAAGGCTATTTCTTGG 19
Vaccinia 79413 TTGAAA-ACTATTTCTTGG 79430
|||||| .|||||||||||
hsa-miR-488 1 TTGAAAGGCTATTTCTTGG 19 |
17/19
17/19 |
(89.5%)
(89.5%) |
| hsa-miR-3128 |
Variola 101249 GCAAGTAGAAAACCTCTCAT 101268
||||||| ||||.|||||||
hsa-miR-3128 5 GCAAGTA-AAAAACTCTCAT 23
Vaccinia 110393 GCAAGTAGAAAACCTCTCAT 110412
||||||| ||||.|||||||
hsa-miR-3128 5 GCAAGTA-AAAAACTCTCAT 23 |
18/20
18/20 |
(90.0%)
(90.0%) |
| hsa-miR-3668 |
Variola 37271 AATGTAAAGAGTGATCAAA 37289
||||||.|||.||||||||
hsa-miR-3668 1 AATGTAGAGATTGATCAAA 19
Vaccinia 46412 AATGTAAAGAGTGATCAAA 46430
||||||.|||.||||||||
hsa-miR-3668 1 AATGTAGAGATTGATCAAA 19 |
17/19
17/19 |
(89.5%)
(89.5%) |
| hsa-miR-338-3p |
Variola 50015 TCCAG-ATACAGTGATTTTG 50033
||||| || |||||||||||
hsa-miR-338 1 TCCAGCAT-CAGTGATTTTG 19
Vaccinia 59201 TCCAG-ATACAGTGATTTTG 59219
||||| || |||||||||||
hsa-miR-338 1 TCCAGCAT-CAGTGATTTTG 19 |
18/20
18/20 |
(90.0%)
(90.0%) |
| hsa-miR-3121-5p |
Variola 61083 TCCTTTGC--ATTCTATTTA 61100
|||||||| ||||||||||
hsa-miR-3121 1 TCCTTTGCCTATTCTATTTA 20
Vaccinia 70269 TCCTTTGC--ATTCTATTTA 70286
|||||||| ||||||||||
hsa-miR-3121 1 TCCTTTGCCTATTCTATTTA 20 |
18/20
18/20 |
(90.0%)
(90.0%) |
| hsa-miR-1205 |
Variola 30252 CTGCAGGGTATTGTTTTGA 30270
||||||||| |||.|||||
hsa-miR-1205 2 CTGCAGGGT-TTGCTTTGA 19
Vaccinia 39396 CTGCAGGGTATTGTTTTGA 39414
||||||||| |||.|||||
hsa-miR-1205 2 CTGCAGGGT-TTGCTTTGA 19 |
17/19
17/19 |
(89.5%)
(89.5%) |
| hsa-miR-337-3p |
Variola 22077 CTCCTATATCAATGCCTTT 22095
||||||||| .||||||||
hsa-miR-337 1 CTCCTATAT-GATGCCTTT 18
Vaccinia 31241 CTCCTATATCAATGCCTTT 31259
||||||||| .||||||||
hsa-miR-337 1 CTCCTATAT-GATGCCTTT 18 |
17/19
17/19 |
(89.5%)
(89.5%) |
| hsa-miR-6824-3p |
Variola 30621 TCTCTGGT-TTGCTACCCCA 30639
|||||||| ||||.||||||
hsa-miR-6824 1 TCTCTGGTCTTGCCACCCCA 20
Vaccinia 39765 TCTCTGGT-TTGCTACCCCA 39783
|||||||| ||||.||||||
hsa-miR-6824 1 TCTCTGGTCTTGCCACCCCA 20 |
18/20
18/20 |
(90.0%)
(90.0%) |
| hsa-miR-4719 |
Variola 31206 TTACAAATCTATAACATGC 31224
|.||||||||||||.||||
hsa-miR-4719 1 TCACAAATCTATAATATGC 19
Vaccinia 40350 TTACAAATCTATAACATGC 40368
|.||||||||||||.||||
hsa-miR-4719 1 TCACAAATCTATAATATGC 19 |
17/19
17/19 |
(89.5%)
(89.5%) |
| hsa-miR-33a-3p |
Variola 140355 AATGTTTCCACACT-CATC 140372
||||||||||||.| ||||
hsa-miR-33a 2 AATGTTTCCACAGTGCATC 20
Vaccinia 149598 AATGTTTCCACACT-CATC 149615
||||||||||||.| ||||
hsa-miR-33a 2 AATGTTTCCACAGTGCATC 20 |
17/19
17/19 |
(89.5%)
(89.5%) |
| hsa-miR-514b-3p |
Variola 69006 ATTGACACATCGGTGAGTG 69024
||||||||.||.|||||||
hsa-miR-514b 1 ATTGACACCTCTGTGAGTG 19
Vaccinia 78192 ATTGACACATCGGTGAGTG 78210
||||||||.||.|||||||
hsa-miR-514b 1 ATTGACACCTCTGTGAGTG 19 |
17/19
17/19 |
(89.5%)
(89.5% |
